AstraZeneca Third Quarter & Nine Months Results 2014

Tomorrow, Thursday, 6 November 2014, AstraZeneca will release third quarter and nine months results 2014 at 07:00 GMT.

An analysts presentation of the third quarter and nine months results will take place at 12:00 GMT and will be accessible by a choice of two routes:

1) Audio webcast available at http://www.astrazeneca.com/investors and http://info.astrazenecaevents.com. You will be able to email questions to the presenters during the Q&A session.

2) Teleconference with Q&A.

Dial in numbers:

UK (freephone):    0800 694 2370
International:         +44 1452 557749
Sweden (freephone):      0200 883 079
USA (freephone):      1 866 977 7645

Conference ID:       29619150#

Printable pdf versions of slides will be available to download on the AstraZeneca Investor Relations website (http://www.astrazeneca.com/investors)15 minutes before the analysts presentation begins.

Details of the teleconference and webcast replay facilities are available on the Investor Relations section of the AstraZeneca website http://www.astrazeneca.com/investors and the AstraZeneca Events website: http://info.astrazenecaevents.com.

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com

Subscribe

Documents & Links